AI-DRIVEN DRUG TARGET IDENTIFICATION IN NEURODEGENERATION: APPLICATIONS IN ALZHEIMER’S, PARKINSON’S, AND ALS RESEARCH. GCM. 2026;1(6):709-721. Accessed August 19, 2026. http://www.econferencia.com/index.php/5/article/view/1216